Connect with us

Health

Britain to sign cancer treatments deal with Germany’s BioNTech

Published

on

Research into new cancer treatments could be sped up by a government deal with a leading pharmaceutical company, British Health Secretary Steve Barclay has said.

Barclay is due to sign a memorandum of understanding with Germany’s BioNTech on Friday, to “ensure the best possible treatments are available as soon as possible” for cancer.

The agreement means cancer patients in England will get early access to trials exploring personalised messenger ribonucleic acid (mRNA) therapies, like cancer vaccines, possibly from as early as autumn this year.

BioNTech worked with Pfizer to develop the widely-used mRNA vaccination against COVID-19, and its partnership with the British government could deliver 10,000 doses of personalised therapies to British patients by 2030 through a new research and development hub.

Barclay said: “Once cancer is detected, we need to ensure the best possible treatments are available as soon as possible, including for breast, lung, and pancreatic cancer.

“BioNTech helped lead the world on a COVID-19 vaccine and they share our commitment to scientific advancement, innovation and cutting-edge scientific technology, making them perfect partners for a deal to work together on cancer vaccines.”

He added: “This partnership will mean that, from as early as September, our patients will be among the first to participate in trials and tests to provide targeted, personalised, and precision treatments using transformative new therapies to both treat the existing cancer and help stop it returning.

“This agreement builds on this government’s promise to increase research and development spending to £20 billion ($23.8 billion) per year and demonstrates the UK remains one of the most attractive places in the world for innovative companies to invest in research, trial new treatments and treat patients more effectively.”

Prof. Uğur Şahin, chief executive and co-founder of BioNTech said: “The UK successfully delivered COVID-19 vaccines so quickly because the National Health Service, academia, the regulator and the private sector worked together in an exemplary way.

“This agreement is a result of the lessons learnt from the COVID-19 pandemic.

“Drug development can be accelerated without cutting corners if everyone works seamlessly together towards the same goal.

“Today’s agreement shows we are committed to do the same for cancer patients.”

Şahin added: “Our goal is to accelerate the development of immunotherapies and vaccines using technologies we have been researching for over 20 years.

The collaboration will cover various cancer types and infectious diseases affecting collectively hundreds of millions of people worldwide.

“If successful, this collaboration has the potential to improve outcomes for patients and provide early access to our suite of cancer immunotherapies as well as to innovative vaccines against infectious diseases – in the UK and worldwide.”

Health

Outbreak: Zamfara Govt. confirms 4 deaths, 177 cases

Published

on

The Zamfara Commissioner for Health, Dr Aisha Anka has confirmed the outbreak of unknown illness in the state which recorded four deaths and 177 cases so far.

Anka confirmed this in a statement issued in Gusau on Friday by the Information Officer of the ministry, Malam Bello Ibrahim.

According to the commissioner, the disease is characterized by abdominal distension, accumulation of fluid in the abdomen, enlarge liver, enlarge spleen, fever and general body weakness.

“The illness is found in Maradun, Shinkafi and Gusau local government areas in the state.

“Children are mostly affected and the cases are associated with water consumptions.

“So far, four deaths have been recorded, 177 cases were detected,” Anka said.

“The incident has been reported to the National Centre for Disease Control (NCDC), partners and all other relevant stakeholders.

“The ministry of health is currently on the emergency response phase to identify the illnesses and causes.

“Various biological human and animal samples, soil samples, water samples, agricultural and foodstuff samples have been taken to Lagos and Abuja laboratories for analysis.

“The ministry will continue to update the general public and all relevant stakeholders and partners on any update about the outbreak,”she added. (

Continue Reading

Health

Assembly passes Kano Pre-Marital Health Screening Bill

Published

on

Kano State House of Assembly has passed a bill for a law to compel intending couples to undergo HIV, hepatitis and sickle cell anaemia screening before marriage.

The passage followed deliberations in the Committee of the Whole House during plenary session,
presided over by the Speaker, Ismail Falgore on Monday in Kano.

After deliberations, the lawmakers approved the 3rd reading of the bill, read by the Deputy Clerk, Alhaji Nasiru Magaji.

Shortly after passage of the bill, the Majority Leader of the house, Lawan Hussein (NNPP-Dala), stated that “any person
intending to marry shall first submit self for medical examinations.”

He said the bill was considered and passed after the 3rd reading, following various legislative processes.

The leader further said that the bill was passed because the state had been battling with different health issues, including
HIV because people go into marriages without medical screening.

He said that the bill, if signed into law, would save many lives and curb the spread of life-threatening diseases.

“The bill will safeguard the health of citizens by institutionalising pre-marital testing to check the spread of diseases
like hepatitis, HIV and sickle cell anaemia,” he added.

Continue Reading

Health

WHO to begin vaccination against Human Papilloma Virus May 27 in Kogi

Published

on

The World Health Organisation (WHO), says it plans to commence vaccination against Human Papilloma Virus (HPV) on May 27 in Kogi.

The state’s Team Lead of WHO, Dr Muktar Toyosi, said this when he led his team on an advocacy visit to the State Council of the Nigeria Union of Journalists (NUJ) on Wednesday in Lokoja.

Toyosi said that the vaccination was meant for girl child of between the age nine and 14.

He said the ongoing sensitisation was to keep the people informed, and educate them on the vaccination of their children to protect them against cervical cancer in future.

”Kogi falls within the second phase of the programme. We are soliciting for the cooperation of the media in educating the people of the state on the HPV vaccination.

“There need for girls child across the state to take the vaccination to safeguard their future.

“Although the vaccine was initially scarce and difficult to get, the good news now is that it has been made available by the government,” Toyosi said.

Also speaking, the State Technical Assistant for WHO, Dr Ahmed Attah, said that the HPV mostly affect women, adding that the vaccination remained a preventive measure against the disease.

Attah, a former state Chairman of the Nigeria Medical Association (NMA) and a former Chief Medical Director (CMD), Kogi Specialist Hospital (KSSH) Lokoja, urged parents and guardians to avail their children of the vaccination to justify government’s investment.

In his response, the Kogi NUJ Chairman, Mr Seidu Ademu, described the health sector as very critical, stressing that the vaccination was a right step in the right direction.

Ademu promised a robust partnership with WHO to enable the team to achieve its set goals.
He stressed the need to inform, educate and sensitise the general public on the need to embrace the vaccine by ensuring that girls within the age range were vaccinated.

Continue Reading

Trending